Statin therapy associated with decreased neuronal injury measured by serum S100β levels in patients with acute ischemic stroke

BACKGROUND: Acute ischemic strokes (AIS) are a common cause of morbidity, mortality, and disability. The serum biomarker S100β correlates with poor neurological outcomes in the setting of AIS. This study describes the impact of statin treatment on S100β levels following AIS. METHODS: This was a pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Kuraishy, Hayder M., Al-Gareeb, Ali I., Naji, Marwa Thaier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725813/
https://www.ncbi.nlm.nih.gov/pubmed/35070915
http://dx.doi.org/10.4103/IJCIIS.IJCIIS_7_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725813/
https://www.ncbi.nlm.nih.gov/pubmed/35070915
http://dx.doi.org/10.4103/IJCIIS.IJCIIS_7_20

Ejemplares similares